Tech Company Financing Transactions

PaxVax Funding Round

Private investors participated in a $6 million venture round for PaxVax. The round was announced on 4/21/2014.

Transaction Overview

Company Name
Announced On
4/21/2014
Transaction Type
Debt
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
555 Twin Dolphin Dr. 360
Redwood City, CA 94065
USA
Email Address
Overview
PaxVax is initially focused on delivering vaccines for the travelers markets. An estimated 100 million people (families, students, workers and soldiers) per year travel to developing countries where tropical diseases are endemic and vaccines are needed for protection.
Profile
PaxVax LinkedIn Company Profile
Social Media
PaxVax Company Twitter Account
Company News
PaxVax News
Facebook
PaxVax on Facebook
YouTube
PaxVax on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Nima Farzan
  Nima Farzan LinkedIn Profile  Nima Farzan Twitter Account  Nima Farzan News  Nima Farzan on Facebook
Chief Financial Officer
Philip Moody
  Philip Moody LinkedIn Profile  Philip Moody Twitter Account  Philip Moody News  Philip Moody on Facebook
Chief Medical Officer
Lisa Danzig
  Lisa Danzig LinkedIn Profile  Lisa Danzig Twitter Account  Lisa Danzig News  Lisa Danzig on Facebook
Chief Scientific Officer
Jonathan Smith
  Jonathan Smith LinkedIn Profile  Jonathan Smith Twitter Account  Jonathan Smith News  Jonathan Smith on Facebook
VP - Bus. Development
Mark Meltz
  Mark Meltz LinkedIn Profile  Mark Meltz Twitter Account  Mark Meltz News  Mark Meltz on Facebook
VP - Human Resources
Britt Huber
  Britt Huber LinkedIn Profile  Britt Huber Twitter Account  Britt Huber News  Britt Huber on Facebook
VP - Operations
Kurt Reichen
  Kurt Reichen LinkedIn Profile  Kurt Reichen Twitter Account  Kurt Reichen News  Kurt Reichen on Facebook
VP - Regulatory Affairs
Marc Gurwith
  Marc Gurwith LinkedIn Profile  Marc Gurwith Twitter Account  Marc Gurwith News  Marc Gurwith on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/19/2014: Engage3 venture capital transaction
Next: 4/21/2014: Placester venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary